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ABSTRACT
ZOE MULLINS TENNER: Observation and Detection of ADHD Malingering in College
Students
(Under the direction of John Young)
The rate of college students attempting to obtain Attention-Deficit/Hyperactivity
Disorder (ADHD) diagnoses in order to gain access to prescription stimulant medications has
shown a large increase over the past 20 years. Research has also shown that college students are
frequently able to convincingly present themselves as meeting clinical criteria for ADHD with
relative ease, meaning that the barrier to false presentation for the purpose of obtaining
inappropriately prescribed medication is minimal. There is a need for more concise, accurate
tools to detect these efforts in clinical settings, which is an area of research pursued by members
of the University of Mississippi faculty (Ramachandran et al., 2019). The current study sought to
examine this tool in the context of simultaneous administration of several other measures of
anxiety, depression, stress, and ADHD in a partially randomized trial. A total of 68 individuals
(57 female; 11 male) were recruited to respond to a battery of self reports and participate in a
verbally-administered, structured clinical interview for ADHD. Respondents were assigned to
one of three groups: 1) ADHD; 2) normal responding; or 3) malingering. The first group was
based on self-reported, historical, formal diagnosis and the latter two were randomly assigned.
Results indicated that group assignment was a significant predictor of overall score on the
malingering detection measure, but score on this measure did not reliably distinguish all three
groups. Additionally, no patterns from overall responses to the other measures emerged that
could accurately discriminate malingering from true ADHD. These findings are in contrast with
previous research done on this campus indicating highly reliable detection of malingering
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(Ramachandran et al., 2019). The implications of these issues, particularly in terms of
developing more refined methods of malingering detection, are discussed.
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I.

INTRODUCTION

Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention and/or hyperactivity-impulsivity that interferes with functioning or
development. (NIH 2021) The DSM-5 criteria for ADHD state that individuals with ADHD
consistently show symptoms of hyperactivity-impulsivity and/or inattention that interfere with,
or reduce the quality of, social, school, or work functioning. Some of these symptoms include
often making careless mistakes in schoolwork, having trouble holding attention on tasks or play
activities and being easily distracted. Similarly, symptoms of hyperactivity include often leaving
one's seat in situations when remaining seated is expected, talking excessively, and having
trouble waiting a turn. In order to make a clinical diagnosis at least six symptoms of one or both
domains (i.e., inattention and hyperactivity/impulsivity) must be present in children up to age 16,
which is altered to five symptoms for individuals 17 years of age or older. Additionally, there
must be some evidence that several of the symptoms were present before age 12 in two or more
settings and resulted in functional impairment (APA, 2013).
These symptoms often result in numerous difficulties for afflicted individuals. In
particular, college students with ADHD face frequent problems acquiring and implementing
age-appropriate social skills, which can negatively impact self-esteem. For example, one study
found that students with ADHD diagnoses experienced decreased functioning in areas of college
adjustment and lower levels of social skills and self-esteem in comparison to a group of their
non-diagnosed peers (Shaw-Zirt, Popali-Lehane, Chaplin, & Bergman, 2005). Multiple studies
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comparing the grade point average of college students with ADHD diagnoses to those without
have also shown significantly lower mean grades for the students with ADHD diagnoses
(Frazier, Youngstrom, Glutting, & Watkins, 2007; Heiligenstein, Guenther, Levy, Savino, &
Fulwiler, 1999). One of these studies also found that college students with ADHD diagnoses also
had significantly lower admission test scores and higher rates of withdrawal from classes
(Advokat, Lane, & Luo, 2010). Similarly, there is evidence that rates of emotional disturbance
differ between groups diagnosed with ADHD and those who are not, in that Heiligenstein et al.
(1999) found significantly higher rates of both depression and anxiety in the former.
Additionally, deficits in overall executive functioning of students with ADHD have been shown
to have significantly lower capability for emotional control than non-diagnosed comparison
groups (Weyandt et al., 2009).
Etiology
Clinically significant impairments in attention, hyperactivity, and impulsivity are
considered to be primarily neurological in origin, and thus the biological basis of ADHD is
believed to be related to chemical imbalances in neurotransmitter pathways. In particular,
scientists have observed a correlation between reduction of dopamine synaptic markers in the
dopamine reward pathway and inattention symptoms in adults with ADHD (Volkow et al., 2009).
Various studies have also shown differences in brain size, networks, and neurotransmitters in
children with ADHD, but the contribution of these differences to ADHD is not fully understood
(American Academy of Child & Adolescent Psychiatry, 2017). Research done with twin and
family studies also suggests a genetic basis for ADHD and certain genetic markers have been
found that correlate specific alleles (i.e., the DAT1 gene locus) with ADHD diagnosis (Sharp,
McQuillin, & Gurling 2009). The implications of a model that predominantly considers the
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causes of this disorder as organic in nature are that the symptoms are likely to persist across the
lifespan in the absence of external intervention.
ADHD Prevalence and Overdiagnosis
In 2006, the prevalence of adult ADHD was estimated to be 4.4% in the United States
(Kessler et al., 2006). In a more recent study, 8.4% of all children in the U.S. (age 2-17) were
estimated to be diagnosed with ADHD (Danielson et al., 2018). Worldwide, the prevalence of
ADHD was estimated through a meta-analysis of 175 research studies which found the rate to be
7.2% for children (Thomas et al., 2015). Separate examinations of trends in these data suggest
that the rate has been rising throughout the past several years. Data from the National
Ambulatory Medical Care Survey, for example, showed an increase by 36% for adult ADHD
diagnosis and 18% for children comparing samples collected in 2008-2009 and 2012-2013
(Fairman, Peckham, & Sclar, 2013).
The rising rates of ADHD could potentially be explained by the growing and highly
publicized problem of ADHD overdiagnosis in college students. In a study done with students at
a private university, over half (54%) of the students who reported having a prior professional
ADHD diagnosis and were later assessed via standardized methods did not report clinically
significant symptoms (Wood et al., 2019). These students were categorized as a “low symptom”
group and their results were compared to controls with no history of ADHD symptoms, which
resulted in no significant differences(Wood et al., 2019). Although the reasons for this finding
were not elucidated by the study, the findings endorse the proposition that many students in
college might have inaccurate ADHD diagnoses.
The overdiagnosis of ADHD happening in college aged students could be attributable to
many different causes, one of which is potential lack of specificity in ADHD symptoms in terms
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of discriminating pathological levels from typical college student behavior. There are multiple
tests designed to aid in objective diagnosis of ADHD, some of which may poorly discern
differences between groups. In a recent study, for example, a general (non-selected) sample of
college students from Syracuse University answered a questionnaire about the frequency of
experiencing various symptoms of ADHD using a standardized measure. Examples of these
symptoms were: “difficulty organizing tasks and activities'' or “avoid, dislike, or reluctant to do
work that requires sustained mental effort.” The results showed that while students with
self-reported, professional ADHD diagnoses reported more symptoms than those without, similar
symptoms were also reported by 30% of the non-ADHD participant group. Based on six
symptoms from the DSM-IV, the diagnostic sensitivity (i.e., the ability of the measure to
accurately detect positive cases) was 0.84 and the specificity (i.e., the ability of the measure to
accurately detect negative cases) was 0.70. The positive predictive power (i.e., overall accurate
classification of positive cases) was 0.52, which suggests the equivocal ability of the measure to
successfully discriminate individuals with and without ADHD on the basis of endorsing six or
more symptoms in a single domain. On the other hand, the negative predictive power (i.e.,
overall accurate classification of negative cases) at this cutoff was 0.93, which demonstrated that
those reporting fewer than six symptoms could be reliably indicated to not have clinical levels of
concern (Lewandowski, Lovett, Codding, & Gordon, 2008).
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ADHD Stimulant Treatment
Stimulant medications are the most commonly used form of treatment for ADHD (CDC,
2021). These medications work by increasing the neurotransmitters dopamine and
norepinephrine (NIH, 2021). These medications have been demonstrated to be effective in
reducing ADHD symptoms, namely in improving attention, focus, and hyperactivity (Charach,
Ickowicz, & Schachar; 2004). These medications have also been found to be very commonly
prescribed. For example, using data from a nationally representative household population study,
Compton et al. (2018) found that the prevalence of U.S. adults receiving prescription stimulants
in the course of the previous year was estimated to be 6.6%, which translated to approximately
16 million adults. In accord with the increasing rates of ADHD diagnosis, the rates of stimulant
prescription have also gone up. Between 1994 and 2009, the proportion of adult psychiatrist
office visits in which stimulants were prescribed increased 6-fold (Olfson, Blanco, Wang, &
Greenhill, 2013). Looking at some of the most specific, commonly prescribed stimulants such as
amphetamine and methylphenidate, data suggest somewhat divergent patterns. In a large study
using data from the US Drug Enforcement Agency, prescription amphetamine use increased 2.5
fold from 2006 to 2016, while methylphenidate peaked in 2012 then declined over the next four
years (Piper et al., 2018). These trends were similar in treatment of children with ADHD in the
2016 National Survey of Children’s Health, wherein an estimated 62% of children diagnosed
with ADHD were taking prescription stimulant medication (Danielson et al., 2016).
A problem with the growing number of prescribed stimulants is the increased misuse of
these drugs, especially among adults (Weyandt et al., 2016). Approximately 5 million adults have
been noted to misuse prescription stimulants, with 1.9% of U.S. adults misusing stimulants in a
way that did not connote meeting criteria for a substance use disorder and 0.2% in a way that did
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meet criteria (Compton et al., 2018). Illicit use of stimulants has also been seen at high rates
across college campuses. In a random sample of 4,580 college students, 8.3% of students
reported having illicitly used prescription stimulants in their life and 5.9% reported illicit use
during that year. 75.8% of these students reported misusing Adderall, and approximately one
fourth reported misusing methylphenidate (Teter, McCabe, LaGrange, Cranford, & Boyd, 2006).
In a national study of college students from 119 colleges and universities, the prevalence of
stimulant misuse ranged from 0% to 25%, and approximately 10% of colleges had a prevalence
of 10% or higher (McCabe, Knight, Teter, & Wechsler, 2005). Out of 115 students that were all
prescribed medication for their professionally diagnosed ADHD, 26% admitted to diverting
medication to other students (Rabiner et al., 2009). Similarly, in a study done at Ole Miss
(discussed further below) 35% of students reported misusing prescription stimulants
(Ramachandran et al., 2019).
Students without prescriptions are often motivated to use ADHD medication in order to
improve their academic performance (Rabiner et al., 2009). Of the students who reported
illicitly using stimulants from the previously mentioned study involving 4,580 college students,
65.2% reported their motive for the illicit drug use to be help with concentration, 59.8% for help
with studying, and 47.5% for increased alertness (Teter, McCabe, LaGrange, Cranford & Boyd
2006). Students of another study reported that their reasoning behind stimulant use, whether
prescribed to them or taken illegally, was to improve academic performance by increasing
concentration and organization, as well as having the ability to remain awake for longer periods
of time to study (Advokat, Guidry, & Martino, 2008). In combination with the finding that most
college students who are prescribed stimulants believe that the medication has improved their
grades as well as their social interactions (Pillow, Naylor, & Malone, 2014), this belief in
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positive benefits could also be generalized to the non-ADHD student population. In turn, that
could contribute to students who are struggling with their adjustment to the collegiate setting to
seek a professional diagnosis of ADHD in order to gain access to stimulant medication and
benefit from its perceived effects (Shaw-Zirt, Popali-Lehane, Chaplin, & Bergman, 2005).
Additionally, perception of stimulant medications as relatively safe may also contribute to
propensity for their misuse. For example, out of a group of students that reported previous illicit
use of stimulant medication, 70% of them perceived slight or no risk associated with illicit
stimulant use (Garnier & Arria et al., 2010).
In a small study done with Ole Miss students, all of the students interviewed listed
academic pressures as the primary motive for stimulant use (Wagner, 2016). In addition to
improved academic performance, another reason stimulants are misused among college students
might be that selling prescription stimulants to other students makes money for those with the
prescription. An estimated 53-62% of students that are prescribed stimulants admit to having
sold or given their prescription to other students (Destantis et al., 2013).
Despite the non-harmful, low-risk guise of these medications, the widespread misuse and
illegal student-student distribution of prescription stimulants is actually dangerous and
problematic for several reasons. The American Addiction Center has a list of several negative
long term effects of Adderall use on health that include problems such as depression, mood
swings, hallucination, anxiety, heart disease, and thoughts of suicide. Scientific studies have also
looked at the impact of amphetamine use on the composition of the brain and long term use has
been shown to decrease the amount of grey matter in the brain, which could cause severe
problems for learning and memory (Berman, O’Neill, Fears, Bartzokis, & London, 2008).
Another harmful consequence of amphetamine use is the addictive nature of amphetamines.
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Some abusers of amphetamines snort them, which yields faster, more potent effects but also
increases the chances for potential addiction (American Addiction Center, 2021). A final concern
for college students misusing stimulants is that the distribution and use of these prescription
drugs is illegal. College students who are seemingly giving helpful study drugs to their friends
are actually risking serious legal action. Possession can lead to fines and potentially time in jail,
while selling the stimulant drugs would result in even heavier fines and up to 30 years in jail for
a single infraction (MS Code § 41-29-139; 2013).
Malingering
The issue of legality, the pressure of school and the seemingly harmless nature of
stimulants could easily lead many students to falsely present themselves in a clinical setting (i.e.,
malinger) in order to obtain a prescription for stimulant drugs. The degree to which this is
possible to do in convincing fashion has been studied previously. In a study done at Louisiana
State University in 2005, for example, undergraduate students were placed into control (normal
responding), simulate (malingering), or ADHD (non-randomly assigned on the basis of a history
of previous ADHD diagnosis) groups. The simulate group was instructed to “convince the
experimenter that you have ADHD.” All participants completed several self-report symptom
tests, structured diagnostic interviews, performance tests that measure attention, and effort tests,
including the Word Memory Test (which is designed to detect feigned cognitive impairment;
Green and Astner, 1995). This single method to examine validity under these conditions
correctly identified 27 simulators (out of 50) and 100% of the control group. The researchers also
brought in an independent clinical psychologist to identify each participant as either a simulator,
control, or ADHD group member. Almost 44% of the simulate group were misclassified by the
psychologist who believed them to be in the ADHD group (which was composed of participants
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showing clinically significant ADHD symptoms). These results suggest that most college
students are able to feign ADHD in a clinical setting in order to gain access to whatever benefits
they may seek (Booksh et al., 2010).
A similar study also used the WMT to evaluate the accuracy and efficiency of ADHD
tests. The participants for this study were actual patients seeking an ADHD diagnosis.
Participants that failed the WMT were placed into a “non-credible” group. The non-credible
group did not significantly differ from the ADHD diagnosis group in their responses to current
ADHD symptoms reported or in their account of retrospective childhood symptoms. Among
other tests and structured interviews, participants completed the Conners Adult ADHD Rating
Scale Self-Report (CAARS). The CAARS manual characterizes t scores above 80 on any of the
subtests as possible evidence for symptom exaggeration, but the manual also reasons that scores
this high could represent severity of symptoms in individuals with ADHD. Of the non-credible
group, 65% scored above 80 on the CAARS e-scale which focuses on symptoms of inattention.
Additionally 33% of the non-credible students scored above 80 on the CAARS f-scale (Suhr,
Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008), which is designed to check validity
under conditions of typical self-report. The results of this study suggest that adding tests such as
WMT and CAARS could assist in determining malingerers of ADHD, but also provides
additional indication that there are individuals in applied clinical settings who successfully
attempt to feign ADHD (Suhr, Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008).
In a similar malingering study done at UCLA, introductory psychology students were
instructed to read the DSM-IV criteria for ADHD. Then, the students were instructed to answer
four commonly used diagnostic tests “as if they were afflicted with the disorder” (Gieselmann &
Jachimowicz, 2004). The tests used were Wender Utah Rating Scale (WURS), a childhood
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symptom self-report; the Conners Adult ADHD Self-Report of Symptoms (CAARS); the Brown
Adult ADHD Scale (BAAS); and the ADHD Rating scale (ARS). The results of the tests showed
sufficient patterns of symptom endorsement for the researchers to conclude that diagnosis of
ADHD was “significantly falsifiable” (Gieselmann & Jachimowicz, 2004). . The scores were
significantly different from what should have been a 100% negative collection of diagnoses for
the participants in this study. These results confirm the previously mentioned findings of Booksh
et al. (2010) that college students are capable of faking ADHD and the tests are incapable of
detecting it.
Similar results were produced by Sollman, Ranseen, and Berry (2010) as their study
demonstrated the inability of ADHD tests to weed out educated malingerers. The Conners Adult
ADHD Self-Report of Symptoms Test also proved to be incapable of eliminating malingerers in
a study done with undergraduate students given a scenario in which they were asked to present as
though they met criteria for ADHD based on information easily found online describing the
appropriate symptoms. The students feigning ADHD were successful in fabricating self-reports
of ADHD, and the study also found that the students “did not necessarily overreport problems,
and they provided a profile of inattention similar to other college students diagnosed with
ADHD” (Sollman et al., 2010). When considered as a group, the criterion of failure of 2 or more
of these SVTs had a sensitivity of 0.48 and a specificity of 1.00.
Subtle ADHD Malingering Screener
These studies along with several others have shown a need for more accurate instruments
to detect malingering in ADHD. Ramachandran et al. (2019) developed a subtle report scale, the
Subtle ADHD Malingering Screener (SAMS) for this reason. To develop the SAMS, the
researchers used three groups, one of which was instructed to feign ADHD in their responses.
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The other two groups were individuals with ADHD and a control group of non-ADHD
individuals who answered honestly. The participants completed the 10-item SAMS as well as the
Personality Assessment Inventory (PAI), which is a lengthy measure equipped with general
malingering detection scales. The distinction of SAMS scores between all three groups was
significant and the researchers determined that 27 was the cutoff score above which respondents
were classified as malingering (cut off score had the best combination of sensitivity and 89.2%
and specificity 77.8%). The development of this scale is useful because of its simplicity, brevity,
and accuracy as demonstrated in this study. Ramachandran stated that anyone classified as a
“malingerer” by the SAMS in a clinical setting should be referred to a specialist or undergo
additional testing (Ramachandran et al., 2019).
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Purpose of Current Study
The SAMS study developed a useful tool that can be especially helpful in reducing the
overdiagnosis of ADHD in college populations and identifying behavior that may be emblematic
of the intention to misuse potentially dangerous stimulant medication. The current study expands
on the SAMS study by understanding whether or not people can convincingly malinger ADHD
diagnosis, and whether or not the SAMS can detect people who are known to be deliberately
misrepresenting their overall functioning (because they were assigned to do so). Similar to
previous work, the current study will also use ADHD, control, and malingering groups that will
complete several ADHD symptom tests including the SAMS to further explore the accuracy of
this method of detecting malingerers. The three groups will be divided at the beginning of the
survey by asking if the participants have been previously diagnosed with ADHD. Those who
have not will be randomly separated into either a control group (who are instructed to answer all
questions honestly) or a malingering group (who are instructed to answer as if they have ADHD
to the best of their ability). Unlike previous studies, however, the latter group was given no
instruction in how to present themselves to this effect, as well as no time to independently pursue
this knowledge on their own (if they had been so inclined). As a consequence, the current study
will yield information about the potential for an average college student to convincingly
malinger ADHD symptoms using only their own colloquial knowledge of this topic. It was
hypothesized that group would be a significant predictor of SAMS score, and that scores on all
measures would generally discriminate between all groups (such that convergent patterns could
be found to successfully identify malingerers as distinct from ADHD and normal responding
groups).
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II.

METHODS

Participants
The participants were 68 undergraduate students at Ole Miss, 57 females and 11 males.
Some students were recruited from psychology courses through SONA systems (a research
participation software used by the Psychology Department) and received credit for their class.
Others were recruited via information given to Greek Life organizations and received
organizational academic “points” for their participation.
Procedure
The participants first completed a survey through Qualtrics, an online tool for organized
survey administration. The first question of the survey separated the students into their respective
groups, which was given as follows:
“Have you previously been diagnosed with ADHD?”
If students answered yes, then a message with this prompt appeared on their screen:
“For the following questions and interview, please do your best to answer questions as
honestly as possible. Also, your group name is: ADHD - please remember this and
inform the researcher when she asks.”
If the students answered “no” (they did not have a previous ADHD diagnosis), then they were
randomized into either the control or malingering group. The control group’s prompt read:
“For the following questions and interview, please do your best to answer questions as
honestly as possible. Also, your group name is: Control - please remember this and
inform the researcher when she asks.”
The malingering group received this prompt:
“For the following questions and interview, please do your best to answer as though you
had a diagnosis of ADHD. (Attention-Deficit/Hyperactivity Disorder, also sometimes
referred to as ADD). Also, your group name is: Faking ADHD - please remember this
and inform the researcher when she asks.”
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There were 22 participants in the ADHD group that self-reported a previous diagnosis. Of the 46
participants who reported never receiving an ADHD diagnosis, 26 made up the control, or
“Normal,” group and 20 were assigned to the malingering group.
Following the assignment of their group, the participants completed a collection of
surveys (described below). Following completion of the surveys in Qualtrics, the participants
then completed the DIVA structured interview, which was administered by the researcher
verbally, face-to-face on a Zoom call.
Assessment Materials
DASS-21
The Depression Anxiety Stress Scales-21 (DASS-21) is a shortened version of a selfreport instrument used for measuring negative emotional states of depression, anxiety and stress
(Lovibond & Lovibond, 1995). The DASS-21 has three subsections that evaluate anxiety,
depression, and stress. Other studies have used the DASS in the context of individuals with
ADHD and found that elevated symptoms were associated with higher levels of self-reported
anxiety and depression in college students (Wood, Lewandowski, & Lovett, 2019). This previous
use, and demonstration of correlated symptoms, made the measure an ideal choice for
understanding anxiety and depression in the current sample.
Vanderbilt Self-Report Form
The Vanderbilt Self-Report Form is a common diagnostic tool that examines symptoms
of inattention, hyperactivity, and impulsivity. The report presents scores for two different
categories: inattention and hyperactivity. The form asks that participants check a box that
describes their behavior over the past six months and the boxes are titled in a range of four
frequencies starting at “not at all” and going up to “very often.” An example of one of the
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questions for inattention symptoms would be “is easily distracted by extraneous stimuli.”
(NICHQ, 2002). Scores on the measure directly align with diagnostic criteria for inattention and
hyperactivity/impulsivity, which require six or more symptoms to be endorsed at sufficient levels
of severity to indicate diagnosis.
SAMS
As mentioned before, the Subtle ADHD Malingering Screener (SAMS) detects
malingering in adults attempting to feign ADHD in a clinical setting. This is a tool for mental
health professionals to use as indication of a need for further testing or potential malingering.
(Ramachandran et al., 2019). The SAMS Scoring Guide is divided into two sections:
psychological factor and academic factor. Both factors correspond to certain items on the
assessment, and the sum of responses determines whether or not the SAMS score fell into a
range that detected malingering. The respondent is suspected of malingering if the score on the
psychological factor is greater than 15 and the score on the academic factor is greater than 7.
DIVA
The Diagnostic Interview for ADHD in adults (DIVA) was administered to participants
via Zoom. This structured interview is based on the DSM criteria for the diagnosis of ADHD in
adults and it involves self-report of symptoms from childhood as well as current, frequently
occurring symptoms of ADHD in adults. To be considered for a diagnosis of ADHD, an
interviewee must exhibit 5 out of 7 inattention symptoms, exhibit 5 out of 7 hyperactivity and
impulsivity symptoms, and show evidence of impairment in two or more areas of functioning
such as work, self-confidence, or free time. The symptoms must also not be able to be attributed
to another disorder (Kooij & Francken, 2010).
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Data Analysis
Mean scores for each group on each variable of the assessment materials were first
calculated. These were compared across groups using ANOVA and follow-up t tests in order to
gain insights into possible differences in the patterns of symptom responding across groups.
Additionally, a regression was conducted predicting SAMS score on the basis of group
assignment (i.e., ADHD; normal responding; malingering). All analyses were conducted using
SPSS.
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III.

RESULTS

Mean Differences
The mean differences for the malingering group versus the normal responding group
were significant for anxiety, depression, and stress as measured by the DASS-21. Similarly,
differences between these groups were also significant for Vanderbilt Inattention and
Hyperactivity subscales, the SAMS total score, and both subscales of the SAMS. Alternatively,
comparisons between the malingering group and the ADHD group (naturalistically derived, not
randomly assigned) on these same variables were not significant. See Table 1 for depiction of
overall mean scores and standard deviations, and Table 2 for statistical comparisons across
groups. Additional information on means and standard deviations by diagnostic status appear in
Tables 3 - 6 (below).
Table 1: Descriptive Statistics of all Measures
N

Mean (Standard Deviation)

Inattention (DIVA)

68

4.59 (3.27)

Hyperactivity (DIVA)

67

4.69 (3.25)

Vand. Inattention

70

3.69 (3.02)

Vand. Hyperactivity

70

3.71 (3.10)

DASS Anxiety

70

6.19 (5.11)

DASS Depression

70

5.06 (4.81)

DASS Stress

70

9.17 (5.28)

SAMS

70

26.46 (14.27)

SAMS Psychological

70

16.36 (8.60)

SAMS Academic

70

10.1(6.15)
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Table 2: Mean Scores by Group
Mean (SD)
ADHD

Malingering

Normal

DIVA Inattention

6.95 (1.84)

6.6 (1.88)

1.04 (1.37)

DIVA Hyperactivity

7.00 (1.76)

6.65 (2.4)

1.31 (1.29)

Vanderbilt Inattention

5.45 (2.54)

5.0 (2.79)

1.27 (1.76)

Vanderbilt Hyperactivity

5.82 (2.30)

4.9 (3.04)

1.08 (1.65)

DASS Anxiety

8.64 (4.36)

8.2 (5.32)

2.54 (3.28)

DASS Depression

7.05 (4.95)

6.35 (4.98)

2.08 (2.67)

DASS Stress

11.59 (4.08)

11.35 (4.70)

5.27 (4.39)

SAMS

30.82 (11.01)

36.2 (15.96)

15.9 (7.2)

SAMS Psychological

18.82 (6.46)

22.1 (9.83)

10.19 (4.77)

SAMS Academic

12.0 (5.15)

14.1 (6.84)

5.69 (2.94)

Table 3: Diagnostic Status on DIVA by Group
ADHD Diagnosis (DIVA)
N

Yes

No

ADHD

22

22

0

Malingering

20

18

2

Normal

26

1

25

18

Table 3A: DIVA Subscale Scores by DIVA Group
Group

ADHD Diagnosis
(DIVA)

N

Inattention

Hyperactivity

ADHD

Yes

22

6.95 (1.84)

7.00 (1.76)

No

0

Yes

18

7.00 (1.50)

7.06 (2.13)

No

2

3.00 (.00)

3.00 (1.41)

Yes

1

5.00

3.00

No

25

.88 (1.13)

1.24 (1.27)

Malingering

Normal

Table 4: Vanderbilt Self-Report Subscale Scores by DIVA Group
Vanderbilt Self-Report
Group

ADHD Diagnosis
(DIVA)

N

Inattention

Hyperactivity

ADHD

Yes

22

5.45 (2.53)

5.82 (2.3)

No

0

Yes

18

5.39 (2.62)

5.22 (3.02)

No

2

1.50 (2.12)

2.0 (1.41)

Yes

1

5.0

6.0

No

25

1.12 (1.62)

.88 (1.33)

Malingering

Normal
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Table 5: DASS-21 Subscale Scores by DIVA Group
DASS: Mean (SD)
Group

ADHD Diagnosis
(DIVA)

N

Anxiety

Depression

Stress

ADHD

Yes

22

8.64 ( 4.36)

7.05 (4.95)

11.59 (4.08)

No

0

Yes

18

9.00 (4.97)

6.83 (5.01)

12.06 (4.40)

No

2

1.00 (1.41)

2.00 (1.41)

5.00 (1.41)

Yes

1

1.00

6.00

12.00

No

25

2.60 (3.33)

1.92 (2.60)

5.00 (4.25)

Malingering

Normal

Table 6: SAMS Classification by Group
Suspected Malingering (SAMS)
N

Yes

No

ADHD

22

6

16

Malingering

20

13

7

Normal

26

2

24

20

Table 6A: SAMS Subscale Scores by DIVA Group
Suspected Malingering (SAMS)
Group

ADHD Diagnosis
(DIVA)

N

SAMS

SAMS Psychological

SAMS Academic

ADHD

Yes

22

30.82 (11.01)

18.82 (6.46)

12.0 (5.15)

No

0

Yes

18

38.2 (15.5)

23.3 (9.57)

14.89 (6.73)

No

2

18.0 (5.66)

11.0 (2.83)

7.0 (2.83)

Yes

1

26

13

13

No

25

15.5 (7.04)

10.1 (4.83)

5.40 (2.58)

Malingering

Normal

Regression and ANOVA of SAMS
Table 7 shows the group regression coefficients for SAMS. The overall analysis was
significant, indicating that group was a significant predictor of SAMS total score. Similarly,
analyses for the Psychological Symptoms and Academic subscales were also significant (Tables
8 and 9, below).

Table 7: SAMS Total Score Predicted by Group
Unstandardized Coefficients
B

Std. Error

Constant

42.72

4.15

Group

-7.78

1.87

Standardized
𝜷

-.456

21

t

Sig.

10.28

.000

-4.17

.000

Table 8: SAMS Psychological Subscale Predicted by Group
Unstandardized Coefficients
B

Std. Error

Constant

25.75

2.53

Group

-4.5

1.14

Standardized
𝜷

-.437

t

Sig.

10.165

.000

-3.949

.000

t

Sig.

9.46

.000

-4.07

.000

Table 9: SAMS Academic Subscale Predicted by Group
Unstandardized Coefficients
B

Std. Error

Constant

17.0

1.79

Group

-3.28

.807

Standardized
𝜷

-.448
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IV.

DISCUSSION

Main Findings
The main findings of the study (based on regression analyses) indicated that group was a
significant predictor of SAMS score. In the case of distinguishing normal responding from
deliberate malingering, this conveys some indication that the SAMS worked as expected
(particularly given random assignment to groups to test the instrument’s utility in this task). In
terms of differentiating the malingering from previously diagnosed ADHD participants, though,
these results were less clear. Although these latter two groups were incrementally significant in
terms of predicting ultimate SAMS scores, their actual endorsed values on the measure did not
differ. This indicated that scores on the SAMS could not be used to directly and individually
identify whether or not someone was malingering. This, too, becomes somewhat more difficult
to interpret due to selection bias (i.e., who volunteered to be part of the study) and the lack of
random assignment to the ADHD group (which was naturalistic and based on self-reported
previous diagnosis). Confirmation of diagnosis by direct clinical interview was helpful in
establishing that the ADHD group appeared to meet actual criteria for the disorder; however, the
implications of this 100% consistent confirmation are difficult to untangle given that it is not
what was expected in comparison with previous studies that found extremely high rates of
historical diagnostic inaccuracy (at times more than half of the sample, meaning inaccuracy was
the rule rather than the exception).
To extend and potentially clarify the predictive utility of the SAMS in the context of
results from the entire battery of tests, it was also possible to look at other patterns that might
have emerged. Any differences between the malingering group and both of the other two groups
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could have been used to develop a more complex scaling system to detect malingering.
Unfortunately, no such variables emerged in terms of significant differences between the ADHD
and malingering group (despite broadly significant results separating malingering from normal
responding). Put differently, the malingering group appeared to be successful in presenting
themselves in a way that convincingly matched the patterns of data displayed by people
accurately diagnosed with ADHD. Notably, this was the case not only for symptoms of
inattention, hyperactivity, and impulsivity, but also anxiety and depression (which may not have
been as superficially apparent in terms of symptoms related to the purposes of malingering).
Additionally, it should also be pointed out that the malingering group exhibited this outcome
with no prior preparation or provision of information. This suggests that the ability to
successfully present oneself inaccurately for the purposes of receiving an ADHD diagnosis (and
potentially prescriptions for stimulants) was already present, and that given enough thought or
motivation students could exude it without difficulty. On one level, this is consistent with the
results of previous studies (e.g., Geiselmann & Jachimowicz, 2004; Suhr, Hammers,
Dobbins-Buckland, Zimak, & Hughes, 2008) where students were also able to successfully
present themselves as meeting criteria for ADHD in a way that was not reliably distinguishable
from individuals with accurate clinical diagnoses. A key difference in these results, however, is
that these previous studies provided participants assigned to the malingering group with a list of
ADHD diagnostic criteria and time to review them before asking them to present themselves to
(blind) examiners for assessment. It is thus unclear as to whether or not these students could have
been as successful in malingering using only information they already possessed. Additionally, it
is possible that there could have been time-based differences in publicly disseminated knowledge
about ADHD and the possible positive benefits of stimulant medications. In the current sample
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the results suggested that this knowledge was widespread and easily accessible to respondents,
but 13 or more years ago this might not have been the case.
Explanation for these results is not entirely informed by the current data collected,
although some speculation can be offered. In particular, it has been previously established that
members of Greek organizations (i.e., social fraternities and sororities) are more likely to engage
in risk-taking behaviors, including stimulant prescription misuse (Pollack, Dupaul, Weysandt, &
Anastopoulos, 2018). The University of Mississippi also has a disproportionately high number of
undergraduates enrolled in these organizations (37%; Princeton Review, 2015) and the current
sample comprised more than 50% Greek affiliation. Additionally, there is recent, previous
evidence from this campus to indicate an association between Greek membership and stimulant
prescription misuse specifically (Witcraft, Smith, Pollard, & Dixon, 2018). Similarly, eight
participants in Ramachandran et al.’s (2019) study (also conducted at the University of
Mississippi) reported a previous attempt to malinger an ADHD diagnosis for the explicit
purposes of obtaining prescription stimulant medication. Although these observations do not
establish a link between Greek life and widespread knowledge of ADHD criteria and/or methods
of malingering, it poses an interesting question for future research.
The overall interpretation of this collective set of results, wherein randomly assigned
undergraduates were readily able to convincingly present themselves as meeting diagnostic
criteria for ADHD are potentially alarming. If the criteria for ADHD are widely known, the
perceived benefits of stimulant use are broadly accepted (primarily in terms of enhancing
academic performance), and students are able to easily convey diagnostic status, then the
potential accessibility of inappropriate (yet formal and fully legal) stimulant prescription is
extremely high. As a consequence, it is logical to infer that many students will avail themselves
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of these opportunities, resulting in further perpetuation of over-diagnosis of ADHD, stimulant
misuse, and possible downstream negative outcomes related to this misuse (as outlined in the
introduction). Additionally, the implications for healthcare service mechanisms to do more to
accurately detect malingering in clinical settings are possibly very high. At the least, it may be
warranted to educate providers about the increasing trend, particularly among college students,
of pursuing formal prescriptions by malingering. Additional education and/or provision of tools
designed to facilitate better measurement may also be helpful as research literature in this area
develops.
Limitations and Future Directions
Potential limitations to this study could be the representativeness of the participant pool.
The study had only 68 participants across three different groups, most of whom were females
affiliated with Greek organizations. The strong gender disparity (i.e., 57 females and 11 males)
precluded any ability to statistically examine gender differences, which have been notable in
terms of presenting symptoms in a previous meta-analytic study (Gershon, 2002). Additionally,
this extreme difference in study participation is atypical in comparison to previous examinations
that reported a gender ratio of 1:1.5 males:females (Shaw-Zirt, et al. 2015). Thus, the degree to
which these results may generalize to other populations (e.g., college students from other
universities; adolescents in high schools; the general population) is unknown. Another possible
limitation of study methods was that interview meetings were conducted via Zoom (due to
pandemic restrictions on in-person research), which could have had an unknown impact on
results. There were several instances where connection issues impaired fluid administration of
the DIVA interview, including one where the connection was lost entirely and could not be
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re-established. Thus, in-person interviews may have proceeded more smoothly and individual
presentation could have been different.
Additionally, one aspect of the study that could have been better executed was the
instructions for the students who were in the malingering group. Two of the students randomly
assigned to this group by Qualtrics indicated during their subsequent Zoom interviews that they
were confused by the instructions and thought they were supposed to fill out the survey honestly
(i.e., without malingering). These participants were recategorized as being in the normal
responding group after being instructed to answer questions on the DIVA in the same manner
(without attempting to present as though they had a diagnosis of ADHD). This accounts for the
uneven number of participants in the normal and malingering groups, although it somewhat
violates random assignment of these two participants. Regardless, it was indicative of the
potential need for subsequent studies employing similar methods to be more detailed in their
descriptions of behavioral expectations. For example, other previous studies assigning people to
a group to deliberately malinger had much more detailed prompts, which retrospectively might
have served as models for the current effort (Booksh et al., 2010; Sollman et al., 2010).
Other limitations are less specific to this study and more general in terms of the nature of
ADHD diagnostic criteria. Previous studies examining these topics have noted that many of the
symptoms necessary for diagnosis are commonly experienced by college students, particularly
those experiencing adjustment difficulties (e.g., Lewandowski et al., 2008). The manifestation of
symptoms and behaviors that specifically connote ADHD may thus be harder to discern due to
the multitude of other reasons someone might exhibit them, including numerous
psychopathological comorbidities (Kessler et al., 2006).
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Much more research will be necessary in the future to clarify both these taxonomic issues
and the methods through which malingering can be detected. It may be particularly beneficial to
examine behavioral methods of ADHD assessment that do not rely as heavily on self-report of
specific symptoms that many people experience for various reasons. Inattention during a lengthy
class lecture may be extremely common among college students, but norm-based measurement
of some more esoteric, brief task could offer different insights into the nature of symptoms.
Similarly, better assessments of the frequency, nature, and extent of functional impairments
experienced on the basis of ADHD symptoms might add to diagnostic clarity and the ability to
detect malingering. It may also be useful to facilitate efforts to develop malingering detection
strategies that do not depend directly on over-reporting ADHD symptoms, as these methods have
shown inconsistent utility in the past. Similarly, expansion of development of subtle (i.e.,
non-obvious or face-valid) methods of detection may also be useful, both in terms of specific
instruments and algorithms based on overall responding to a wider array of tests. Time will tell if
these strategies can be made into viable, easily administered assessment tools, and foundational
work will first be necessary to understand these questions.
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